Comprehensive Notes on General Biochemistry: Metabolism, Bioenergetics, and Control Systems

Fundamental Principles of Metabolism and Bioenergetics

Metabolism represents the vast array of regulated chemical reactions occurring within a living organism to maintain life. These reactions must conform to universal laws of chemistry and physics, specifically thermodynamics. Humans are considered open systems because they constantly exchange energy and heat with their environment. If a living being reaches thermodynamic equilibrium, meaning the input of energy is exactly equal to the output and internal exchanges cease, death follows. Organisms represent the maximum expression of order, maintained by finely-tuned systems such as those regulating ion concentrations. However, to maintain this high internal order, living beings create a greater degree of disorder in their surrounding environment. For example, if a system creates 10 units of order locally, it must produce 15 units of disorder externally to satisfy the laws of physics. The primary final products of human metabolism are carbon dioxide ($CO_2$), water ($H_2O$), and ammonia, which is excreted in the form of urea.

From a thermodynamic perspective, nutrition is the mechanism by which chemical substances enter a biological reality to facilitate growth, energy maintenance, and functional integrity. Catabolism dismantled these nutrients to produce energy used for mechanical work (muscular contraction or phototropism in sunflowers), active transport (moving ions against concentration gradients), and the synthesis of macromolecules. Photosynthesis remains the fundamental energy source for the biosphere; plants transform radiant energy into chemical energy stored in molecular bonds, converting water and carbon dioxide into oxygen and sugars. This process occurs in the chloroplast, an organelle functionally analogous to the mitochondrion but operating in reverse by producing $NADPH$ and $NADP$ that support molecular synthesis.

Thermodynamics and Gibbs Free Energy in Biological Systems

Bioenergetics focuses on the transformation of chemical energy from food into cellular fuel. It is governed by two major thermodynamic laws. The First Law states that energy in a closed system can be converted from one form to another but cannot be created or destroyed. The Second Law states that in any energy conversion, a fraction of the total energy is dissipated as heat, which can no longer be used to perform work. Therefore, biological transformations always involve an increase in total entropy (disorder). There are three primary thermodynamic functions used to describe these reactions: enthalpy ($H$), which measures heat absorbed or released; entropy ($S$), which measures disorder; and Gibbs Free Energy ($G$), which represents the energy available to perform work.

Spontaneity is determined by the variation in free energy ($│G$) defined by the Gibbs-Helmholtz equation: $\Delta G = ΔH - TΔS$. If $\Delta G < 0$, the process is exergonic and occurs spontaneously. If $\Delta G > 0$, the process is endergonic and requires energy input (similar to charging a phone battery). If $\Delta G = 0$, the system is at equilibrium. Crucially, the sign of $\Delta G$ is entirely independent of reaction velocity; some highly spontaneous reactions are extremely slow without enzymatic intervention. In metabolism, unfavorable endergonic reactions are made possible through reaction coupling. For example, the phosphorylation of glucose to glucose-6-phosphate has a positive $\Delta G^0’$, making it non-spontaneous. However, by coupling it to the hydrolysis of $ATP$ ($\Delta G^0’ = -30.5 kJ mol^{-1}$), the net $\Delta G^0’$ for the reaction catalyzed by hexokinase becomes $-16.7 kJ mol^{-1}$, allowing the reaction to proceed.

The Role of ATP and Coupled Reactions

Adenosine Triphosphate ($ATP$) is the chemical currency of the cell. It consists of an adenine base, a ribose sugar, and a tail of three phosphate groups linked by phosphoanhydride bonds. These bonds are highly unstable due to the electrostatic repulsion between the four negative charges on the phosphate groups. Breaking these bonds via hydrolysis releases significant energy. $ATP$ can be dephosphorylated into $ADP + P_i$ ($\Delta G^0 = -30 kcal mol^{-1}$) or into $AMP + PP_i$ ($PP_i$ represents pyrophosphate). In the second case, the pyrophosphate is subsequently split by pyrophosphatase ($\Delta G^0 = -33 kcal mol^{-1}$), resulting in a total release of approximately $-65 kcal mol^{-1}$. This effectively makes reactions involving $AMP + PP_i$ formation irreversible.

Living organisms require a continuous cycle of $ATP$ turnover. While a human body may require the energy equivalent of 4 kg of $ATP$ daily for basal metabolism, only about 5 g of $ATP$ is actually present in the organism at any given time. This small pool is rapidly phosphorylated and dephosphorylated to meet energy demands. Beyond its role as energy currency, levels of $ATP$, $ADP$, and $AMP$ act as critical regulators for metabolic pathways. If $ATP$ levels rise, anabolic pathways (synthesis) are activated; if $ADP$ or $AMP$ levels rise, catabolic pathways (degradation) are stimulated to generate more fuel.

Molecular High-Energy Intermediates

Besides $ATP$, cells utilize other high-energy compounds to store and transfer phosphate groups or electrons. Phosphocreatine ($PCr$), synthesized from amino acids in the liver and kidney, serves as an emergency energy reservoir in muscle and nerve cells. It stores phosphate from $ATP$ during rest and rapidly transfers it back to $ADP$ via creatine kinase ($CK$) during intense physical exertion. Phosphoenolpyruvate ($PEP$) contains the highest energetic potential of these compounds; its hydrolysis releases double the energy of $ATP$ hydrolysis. 1,3-Bisphosphoglycerate is another high-energy intermediate found in glycolysis.

Electron carriers are equally essential. Nicotinamide Adenine Dinucleotide ($NAD^+/NADH$) and Flavin Adenine Dinucleotide ($FAD/FADH_2$) collect electrons during fuel oxidation. $NAD^+$ typically accepts two electrons as a hydride ion ($H^-$) all at once, whereas $FAD$ can accept electrons one at a time, making it involved in radical formation. In aerobic organisms, these electrons are eventually transferred to oxygen ($O_2$), the final acceptor, releasing enough energy to drive $ATP$ synthesis. A key distinction is that $NADH$ is primarily used for ATP-generating catabolic reactions, while $NADPH$ (which contains an additional phosphate group) provides reducing power for anabolic biosynthesis.

Enzyme Kinetics and Strategies of Catalytic Control

Enzymes are the primary protagonists of metabolism, acting as protein-based catalysts that accelerate chemical reactions by lowering activation energy. Metabolism is managed like a continuous assembly line where specific enzymes govern each step. The most critical control points are the "key enzymes," which typically catalyze the first step or the slowest (rate-limiting) step of a pathway. Key enzymes are regulated in three main ways: by altering their catalytic activity (binding the substrate), by changing the quantity of enzyme present (regulating gene transcription), and by managing substrate availability through compartmentalization (e.g., glycolysis in the cytoplasm and oxidative phosphorylation in the mitochondria).

Enzymatic activity is sensitive to environmental parameters. The pH level can denature a protein's three-dimensional structure; while most enzymes function best at physiological pH ($7.4$), those in the stomach (like pepsin) require acidic environments. Small pH shifts, such as those caused by lactic acid production during exercise, can modulate enzyme function to help an athlete adapt. Temperature also affects velocity: increasing temperature generally speeds up reactions until the protein begins to denature. Biological systems utilize several specific strategies for regulation: the availability of precursors, the presence of coenzymes (either free co-substrates like $NAD^+$ or covalent prosthetic groups like $FAD$), and the activation of zymogens (inactive precursors activated by proteolysis, like factors in blood coagulation or digestive enzymes).

Mechanisms of Enzyme Inhibition and Modification

Enzymes are classified into isosteric (fixed shape) and allosteric (shape-shifting) types. Isosteric enzymes are primarily regulated by substrate concentration and inhibitors. Reversible inhibition includes competitive inhibition, where a molecule mimicking the substrate binds to the active site ($K_m$ increases, $V_{\max}$ stays constant); uncompetitive inhibition, where the inhibitor binds only to the enzyme-substrate complex ($K_m$ and $V_{\max}$ both decrease); mixed inhibition; and non-competitive inhibition, where the inhibitor binds regardless of substrate presence ($K_m$ constant, $V_{\max}$ decreases). Statins are a pharmaceutical example, acting as competitive inhibitors of $HMG‐CoA$ reductase to block cholesterol synthesis.

Covalent modification is another powerful regulatory mechanism. Phosphorylation, carried out by kinases using phosphate from $ATP$, and dephosphorylation, carried out by phosphatases, induce conformational changes that can activate or inactivate an enzyme. Generally, catabolic enzymes are activated by phosphorylation while anabolic enzymes are inhibited by it, ensuring that opposing pathways are not active simultaneously. Feedback inhibition is also common, where the final product of a pathway binds to and inhibits the first enzyme in the sequence once concentrations are sufficient, preventing resource waste.

Allosteric Regulation and Cooperative Effects

Allosteric enzymes exist in an equilibrium between two states: the $T$ (Tense) state, which is inactive/low affinity, and the $R$ (Relaxed) state, which is active/high affinity. Allosteric modulators (effectors) can be positive (stabilizing the $R$ state) or negative (stabilizing the $T$ state). These enzymes often consist of multiple subunits and exhibit sigmoid (S-shaped) saturation curves rather than the hyperbolic curves of Michaelis-Menten kinetics. This allows the enzyme to switch from low activity to high activity over a very narrow range of substrate concentrations, providing a molecular "on-off" switch.

Cooperative effects occur in multimeric proteins like hemoglobin or Protein Kinase A ($PKA$). In $PKA$, two regulatory subunits bind cyclic $AMP$ ($cAMP$) as a second messenger, inducing a conformational change that releases two active catalytic subunits. This effect is described by theories such as the "Tutto o Niente" (All or Nothing) model or Koshland’s sequential hypothesis. Effectors are classified into Class K (which affect $K_m$/affinity) and Class V (which affect $V_{\max}$). This sophisticated regulation permits the rapid metabolic adaptations required for survival, such as the "fight or flight" response.

The Citric Acid Cycle (The Krebs Cycle)

The Citric Acid Cycle is the second phase of cellular respiration, occurring entirely within the mitochondrial matrix. It is an amphibolic pathway, meaning it participates in both catabolism and anabolism. The cycle begins with the condensation of oxaloacetate ($4 C$) and acetyl-CoA ($2 C$) to form citrate ($6 C$). Over eight enzymatic reactions, citrate is isomerized to isocitrate, then sequentially decarboxylated and oxidized. The products of one full turn of the cycle are $2 CO_2$, $3 NADH$, $1 FADH_2$, and $1 GTP$ (which is equivalent to $ATP$). The two carbons entering as acetyl groups are eventually lost as $CO_2$ with a net loss of 8 electrons, which are transferred to the coenzymes.

The steps are as follows: (1) Citrate Synthase condenses oxaloacetate and acetyl-CoA. (2) Aconitase isomerizes citrate to isocitrate through a dehydration-rehydration mechanism to move the hydroxyl group to a position susceptible to oxidation. (3) Isocitrate Dehydrogenase performs oxidative decarboxylation, releasing the first $CO_2$ and $NADH$ to form alpha-ketoglutarate ($5 C$). (4) alpha-Ketoglutarate Dehydrogenase (a multienzyme complex with three subunits and five coenzymes: $TPP$, lipoamide, $FAD$, $NAD^+$, and $CoA$) produces succinyl-CoA ($4 C$), second $CO_2$, and $NADH$. (5) Succinyl-CoA Synthetase performs substrate-level phosphorylation to produce succinate and $GTP$. (6) Succinate Dehydrogenase (part of mitochondrial Complex II) oxidizes succinate to fumarate, reducing $FAD$ to $FADH_2$. (7) Fumarase hydrates fumarate to L-malate. (8) Malate Dehydrogenase regenerates oxaloacetate, producing the third $NADH$.

The Electron Transport Chain and Mitochondrial Membranes

Aerobic metabolism culminates in oxidative phosphorylation at the inner mitochondrial membrane. This membrane is highly impermeable, requiring specialty transporters for most ions and molecules. The process consists of two parts: the respiratory chain (electron transport) and ATP synthesis. Electrons from $NADH$ and $FADH_2$ are passed through four protein complexes. Complex I ($NADH$-Coenzyme Q oxidoreductase) accepts electrons from $NADH$ and pumps 4 protons ($H^+$) into the intermembrane space. Complex II (Succinate-Coenzyme Q reductase) accepts electrons from $FADH_2$ but does not pump protons. Coenzyme Q (Ubiquinone), a mobile hydrophobic shuttle, transfers electrons from Complexes I and II to Complex III (Cytochrome bc1 complex), which pumps another 4 protons. Cytochrome c, a small water-soluble protein, then carries electrons to Complex IV (Cytochrome c oxidase), where they reduce $O_2$ to $H_2O$ and pump 2 final protons.

Energy is thus stored in a chemiosmotic gradient across the inner membrane, creating a high concentration of $H^+$ in the intermembrane space ($P$-side) and a low concentration in the matrix ($N$-side). This gradient creates a proton-motive force comprising both a pH gradient and an electrical potential. To reach equilibrium, protons must move back into the matrix. This movement is coupled to $ATP$ production by Complex V (ATP Synthase). For every pair of electrons transferred from $NADH$, 10 protons are moved, enabling the production of approximately 3 $ATP$ (theoretical maximum is 7, but much is lost as heat, with a real-world efficiency of about 40%). $FADH_2$ only moves 6 protons, yielding approximately 2 $ATP$.

Chemiosmotic Theory and ATP Synthase

ATP Synthase is a molecular motor composed of two functional units: $F_o$ and $F_1$. The $F_o$ subunit is embedded in the membrane and contains a trans-membrane channel for protons. As protons flow through $F_o$, they trigger the rotation of the central gamma subunit. The $F_1$ subunit, which projects into the matrix, consists of three pairs of alpha-beta subunits that act as catalytic centers. Due to the rotating gamma subunit, each beta subunit cycles through three conformational states: (1) State $L$ (Lax/Loose), which binds $ADP$ and $P_i$ weakly; (2) State $T$ (Tense), which provides the catalytic environment to condense $ADP + P_i$ into $ATP$; and (3) State $O$ (Open), which releases the newly formed $ATP$. Every three protons passing through the motor result in a $120̀$ rotation and the formation of one $ATP$.

Regulation of this process is primarily dictated by the availability of substrates like $ADP$ and $O_2$. If $ATP$ levels are high and $ADP$ is low, the flow stops. Several molecules can disrupt this balance. Uncoupling agents, such as Thermogenin ($UCP1$) found in brown adipose tissue, allow protons to re-enter the matrix without passing through ATP Synthase. This dissipates the gradient as heat rather than chemical energy, providing warmth for newborns or hibernating animals. In toxicology, Cyanide and Carbon Monoxide ($CO$) block Complex IV, preventing electron transfer to oxygen and triggering rapid cell death. Rotenone and Barbiturates inhibit Complex I, while Antimycin A blocks Complex III. Arsenic inhibits ATP Synthase by mimicking phosphate.

Carbohydrate Digestion and GLUT Transporters

Carbohydrate metabolism is centrally managed by the liver. Digestion begins in the mouth with salivary alpha-amylase and continues in the duodenum with pancreatic amylase, breaking polysaccharides into monosaccharides (glucose, fructose, galactose). Absorption into intestinal cells occurs through the sodium-glucose co-transporter ($SGLUT$), which uses the sodium gradient established by $ATP$-consuming pumps. Once inside, glucose travels through the bloodstream and enters various tissues via specific Glucose Transporters ($GLUT$). Each transporter has unique characteristics: $GLUT1$ is ubiquitous and high-affinity; $GLUT2$ (found in the liver and pancreatic beta cells) has a low affinity but high capacity, allowing the liver to sense blood glucose levels; $GLUT3$ is found in the brain; and $GLUT4$ is insulin-dependent, found in muscle and adipose tissues.

In the presence of insulin (secreted when glycemia rises above $5.5 mM$), vesicles containing $GLUT4$ in muscle and fat cells migrate to and fuse with the plasma membrane, facilitating glucose uptake. When insulin drops, these transporters are internalized. In the liver, glucose-6-phosphate ($G6P$) is the first metabolic branch point. Depending on the body’s state, the liver can store glucose as glycogen, send it through glycolysis for energy (though the liver mostly burns fatty acids for its own needs), or use the pentose phosphate pathway to generate building blocks for synthesis.

Glycolysis: The Central Pathway of Glucose Catabolism

Glycolysis is an anaerobic pathway occurring in the cytoplasm that breaks down one glucose molecule ($6 C$) into two pyruvate molecules ($3 C$). It consists of 10 reactions split into two phases: the Phase of Investment and the Phase of Recovery. In the Investment Phase, two $ATP$ are consumed: (1) Hexokinase phosphorylates glucose to $G6P$; (2) Phosphoglucose isomerase converts $G6P$ to fructose-6-phosphate ($F6P$); (3) Phosphofructokinase-1 ($PFK‐1$), the cycle's most regulated enzyme, consumes the second $ATP$ to produce fructose-1,6-bisphosphate ($F1,6BP$). The Investment Phase concludes with the cleavage of $F1,6BP$ into two trioses (glyceraldehyde-3-phosphate, $GAP$; and dihydroxyacetone phosphate, $DHAP$).

In the Recovery Phase, each triose produces energy: (6) Glyceraldehyde-3-phosphate dehydrogenase produces $NADH$; (7) Phosphoglycerate kinase generates the first $ATP$ through substrate-level phosphorylation; (8) Mutase shuffles the phosphate group; (9) Enolase dehydrates the molecule to form the unstable Phosphoenolpyruvate ($PEP$); and (10) Pyruvate Kinase transfers the final phosphate to $ADP$, yielding the second $ATP$ and pyruvate. The net result for one glucose is $2 ATP$, $2 NADH$, and $2 pyruvates$. Under anaerobic conditions (e.g., in red blood cells or sprinting muscles), $NADH$ must be regenerated into $NAD^+$ by Lactate Dehydrogenase ($LDH$), which reduces pyruvate to lactate. This lactate can travel to the liver, where it is converted back to glucose via the Cori Cycle.

The Pyruvate Dehydrogenase Complex and Aerobic Fate

In aerobic conditions, pyruvate enters the mitochondria to be converted into Acetyl-CoA, the gateway to the Krebs Cycle. This conversion is handled by the Pyruvate Dehydrogenase ($PDH$) complex, a massive assembly of three enzymes: Pyruvate decarboxylase ($E1$), Transacetylase ($E2$), and Dehydrogenase ($E3$). The reaction requires five coenzymes: Thiamine Pyrophosphate ($TPP$), Lipoamide, Coenzyme A ($CoA-SH$), $FAD$, and $NAD^+$. The process follows a specific sequence: (1) $E1$ decarboxylates pyruvate and anchors the hydroxyethyl group to $TPP$; (2) $E2$ takes the hydroxyethyl group, oxidizes it to an acetyl group, and transfers it to a lipoamide bridge, then finally to $CoA-SH$ to form Acetyl-CoA; (3) $E3$ uses $FAD$ and $NAD^+$ to re-oxidize the lipoamide bridge to reset the cycle.

The $PDH$ complex is irreversibly committed once activated, as animals cannot convert Acetyl-CoA back into carbohydrates. Regulation is precise: it is inhibited by its products ($Acetyl‐CoA$, $NADH$) and high energy signals ($ATP$). It is controlled by phosphorylation: $PDH$ kinase inactivates it when energy is abundant (stimulated by high $ATP$), while $PDH$ phosphatase activates it when energy is low (stimulated by $Ca^{2+}$, especially in muscles during exercise). Arsenic poisoning can specifically target the lipoamide groups in $PDH$, blocking energy production.

Gluconeogenesis: The Synthesis of Glucose from Non-Sugar Precursors

Gluconeogenesis is the "exo novo" synthesis of glucose, primarily occurring in the liver ($90$%) and kidneys ($10$%). Humans consume roughly 160 g of glucose daily, with the brain being the primary consumer. When glucose stores (glycogen) are exhausted, the liver must produce glucose from precursors like pyruvate, lactate, alanine, or glycerol. Gluconeogenesis essentially reverses glycolysis but must bypass three irreversible metabolic hurdles: Hexokinase, $PFK‐1$, and Pyruvate Kinase. Using 6 molecules of $ATP$ per glucose molecule, the bypassed steps are: (1) Pyruvate is converted to oxaloacetate in the mitochondria by Pyruvate Carboxylase (using $ATP$ and the biotin coenzyme), then converted to $PEP$ in the cytoplasm by $PEPCK$ (using $GTP$); (2) $F1,6BP$ is converted to $F6P$ by Fructose-1,6-bisphosphatase; (3) $G6P$ is converted to free glucose by Glucose-6-phosphatase (present only in liver and kidney).

Regulation ensures that glycolysis and gluconeogenesis are not active concurrently. Fructose-2,6-bisphosphate is the master regulator: it activates $PFK‐1$ (glycolysis) and inhibits Fructose-1,6-bisphosphatase (gluconeogenesis). Its synthesis is managed by a tandem enzyme ($PFK‐2$/$FBPase‐2$). Insulin lowers phosphorylation of the tandem enzyme to favor glycolysis, while glucagon increases phosphorylation to favor gluconeogenesis. Additionally, stress hormones like cortisol stimulate gluconeogenesis by inducing the transcription of key enzymes in the liver.

The Metabolism and Regulation of Glycogen

Glycogen is a branched polymer of glucose used for energy storage in the liver and muscles. Storing glucose as glycogen avoids the osmotic pressure that free glucose would exert, which could cause cells to burst. The polymer is built on a primer protein called glycogenin. Synthesis ($glycogenesis$) is driven by Glycogen Synthase, which adds glucose units activated as $UDP$-glucose to the non-reducing ends. At the same time, a branching enzyme creates alpha-1,6-glycosidic links periodically. Degradation ($glycogenolysis$) is performed by Glycogen Phosphorylase, which uses inorganic phosphate ($P_i$) to cleave terminal glucose-1-phosphates ($G1P$). This process is energy-efficient because the released glucose is already phosphorylated.

Regulation is coordinated by phosphorylation. Glucagon and adrenaline stimulate the production of $cAMP$, which activates kinases that phosphorylate both enzymes. Phosphorylation activates Glycogen Phosphorylase but inactivates Glycogen Synthase, switching the cell to glucose-release mode. Calcium ($Ca^{2+}$) in muscles also activates degradation to support contraction. Conversely, insulin activates phosphatases ($PP1$) that remove the phosphate groups, activating Glycogen Synthase and inhibiting Glycogen Phosphorylase to facilitate storage. In the liver, glucose itself acts as a negative allosteric effector for Phosphorylase, ensuring that the organ stops breaking down glycogen once blood glucose is high enough.

The Pentose Phosphate Pathway and Antioxidant Defense

The Pentose Phosphate Pathway ($PPP$) is an anaerobic cytoplasmic pathway that oxidizes glucose not for energy, but for two fundamental requirements: reducing power in the form of $NADPH$ and the 5-carbon sugar Ribose-5-phosphate. $NADPH$ is essential for fatty acid and sterol synthesis and for maintaining Glutathione ($GSH$) in its reduced state. Glutathione is the cell's frontline defense against oxidative damage from reactive oxygen species (free radicals); it sacrifices itself to be oxidized into $GSSG$, and $NADPH$ is required to regenerate it via glutathione peroxidase.

The pathway has an irreversible Oxidative Phase, controlled by Glucose-6-phosphate dehydrogenase ($G6PDH$), which produces $NADPH$ and $CO_2$. A genetic deficiency in $G6PDH$ leads to Favism; ingestion of oxidative substances (like those in fava beans) causes mass hemolysis because red blood cells cannot regenerate enough $NADPH$ to combat the oxidative stress. The pathway also has a reversible Non-Oxidative Phase, where enzymes like Transketolase and Transaldolase rearrange sugars. This allows the cell to adapt to different needs: if it needs ribose for DNA replication, it runs the pathway toward ribose; if it needs $NADPH$, it converts the ribose back into glycolytic intermediates to recycle carbon into the oxidative phase.

Metabolism of Fructose, Galactose, and Mannose

Mainstream carbohydrate metabolism centers on glucose, but other sugars are vital. Fructose is absorbed through $GLUT5$ and enters the muscle as $F6P$ via hexokinase. In the liver, it follows a different path through fructokinase to produce fructose-1-phosphate, bypassing the regulated $PFK‐1$ step of glycolysis. This means sedentary individuals consuming high fructose may overproduce Acetyl-CoA, which is then stored as fat, contributing to non-alcoholic fatty liver and hyperuricemia (gout) due to rapid $ATP$ depletion during fructose phosphorylation. Galactose, derived from lactose, is phosphorylated and then converted to $UDP$-glucose via a specific uridyl transferase and epimerase. Lactose intolerance stems from either a lack of the digestive enzyme lactase or the inability to metabolize galactose, leading to severe intestinal issues. Mannose is phosphorylated and isomerized into $F6P$ to enter glycolysis.

Lipid Digestion, Transportation, and Lipoproteins

Lipids are highly energy-dense and hydrophobic, requiring complex systems for digestion and transport. Bile salts from the liver emulsion fats in the intestine, allowing pancreatic lipases to hydrolyze triglycerides. To travel through the aqueous environment of the blood, fats are packaged into Lipoproteins: (1) Chylomicrons transport dietary fats from the intestine; (2) $VLDL$ transport fats synthesized in the liver; (3) $LDL$ ("bad cholesterol") deliver cholesterol to peripheral tissues; (4) $HDL$ ("good cholesterol") collect cholesterol from tissues to return it to the liver. Lipoprotein Lipase ($LPL$) is anchored on capillary surfaces; it is activated by ApoC-II on chylomicrons/$VLDL$ to hydrolyze their payload of triglycerides into fatty acids and glycerol for tissue uptake. A deficiency in ApoC-II results in milky, opalescent plasma due to the persistence of chylomicrons.

The Release and Activation of Fatty Acids

When energy is needed, the body mobilizes triacylglycerols stored in adipose tissue droplets. Glucagon or adrenaline triggers a signalling cascade ($cAMP$ → $PKA$) that phosphorylates Hormone-Sensitive Lipase ($HSL$) and perilipin. Phosphorylated perilipin changes shape to allow $HSL$ access to the fat droplet, releasing Free Fatty Acids ($FFA$). These travel through the blood bound to albumin. To be metabolized, a fatty acid must be activated in the cytoplasm by Acyl-CoA synthetase ($Thiokinase$), which consumes $ATP$ to link the fatty acid to Coenzyme A, forming Acyl-CoA. This activation is irreversible due to subsequent pyrophosphate hydrolysis. Before oxidation can occur, the Acyl-CoA must enter the mitochondrial matrix. Since the inner membrane is impermeable to it, the Carnitine Shuttle is used: Carnitine Palmitoyl Transferase I ($CPT‐I$) exchanges the $CoA$ for carnitine; the resulting Acyl-carnitine is translocated inward, and $CPT‐II$ resets the molecule back to Acyl-CoA within the matrix.

Mitochondrial Beta-Oxidation of Saturated and Unsaturated Fatty Acids

Beta-oxidation is the cyclical process of breaking down fatty acids into Acetyl-CoA. For a standard 16-carbon palmitate, each of the seven cycles consists of four steps: (1) Oxidation/Dehydrogenation by Acyl-CoA dehydrogenase ($FAD$ to $FADH_2$), forming a trans-double bond; (2) Hydration of the double bond; (3) Oxidation by hydroxyacyl-CoA dehydrogenase ($NAD^+$ to $NADH$); (4) Thiolysis by beta-ketoacyl-CoA thiolase, releasing one Acetyl-CoA and leaving behind a fatty acid shortened by two carbons. The oxidation of one palmitate yields a net $129 ATP$ and metabolic water (one kg of palmitate can yield over 9 liters of water, an adaptation utilized by camels). For unsaturated fatty acids (cis-bonds), isomerases and reductases are required to convert the bonds to the trans-configuration standard for beta-oxidation. Odd-chain fatty acids eventually produce propionyl-CoA ($3 C$), which is carboxylated to succinyl-CoA (using biotin and Vitamin $B_{12}$), providing the only path for fats to feed into gluconeogenesis.

Ketogenesis: Formation and Utilization of Ketone Bodies

During prolonged fasting or uncontrolled diabetes, oxaloacetate is diverted from the Krebs Cycle to gluconeogenesis. The resulting buildup of mitochondrial Acetyl-CoA in the liver triggers ketogenesis. Three ketone bodies are produced: acetoacetate, beta-hydroxybutyrate, and acetone (which is a volatile waste product). These molecules are soluble and serve as a vital fuel alternative, especially for the brain, which cannot oxidize fatty acids directly. Once ketone bodies reach target tissues like the heart or brain, they are converted back into Acetyl-CoA and enter the Krebs Cycle. Crucially, the liver lacks the enzyme thiophorase, preventing it from consuming the ketone bodies it produces, ensuring they remain available for peripheral organs.

Biosynthesis of Fatty Acids (Lipogenesis)

Fatty acid synthesis occurs in the cytoplasm when energy is abundant, primarily from Acetyl-CoA. Since Acetyl-CoA is produced in mitochondria and cannot cross the membrane, it is exported as citrate via the Citrate Shuttle. In the cytoplasm, Citrate Lyase releases the Acetyl-CoA. The committed and regulated step is the conversion of Acetyl-CoA to Malonyl-CoA by Acetyl-CoA Carboxylase ($ACC$), which utilizes biotin and is activated by insulin and citrate. The actual construction is performed by the Fatty Acid Synthase ($FAS$) complex, a multifunctional dimer. Through repeated cycles of condensation, reduction (using $NADPH$), dehydration, and reduction, Malonyl-CoA units are added to a growing chain anchored on the Acyl Carrier Protein ($ACP$). The process consumes 14 $NADPH$ and 7 $ATP$ to produce one 16-carbon palmitate. Importantly, Malonyl-CoA inhibits $CPT‐I$, ensuring that fatty acid synthesis and oxidation do not occur at the same time.

Elongation and Desaturation of Fatty Acid Chains

Following its synthesis, palmitate serves as a precursor for longer or unsaturated fatty acids. This "maturation" occurs in the smooth endoplasmic reticulum ($SER$). Elongation follows the same sequence as $FAS$ but uses different enzymes and links the acyl chain to $CoA$ rather than $ACP$. Desaturation involves inserting double bonds, typically in the cis-configuration. Animals possess desaturases for positions 9, 6, 5, and 4. However, they cannot insert double bonds beyond position 9 (the omega end). Therefore, linoleic acid (Omega-6) and alpha-linolenic acid (Omega-3) are essential fatty acids that must be obtained from the diet. These precursors are vital for synthesizing Eicosanoids, such as prostaglandins, thromboxanes, and leukotrienes, which act as local hormones regulating inflammation, blood pressure, and clotting.

Biosynthesis of Triglycerides, Phospholipids, and Sphingolipids

Triglycerides are formed by esterifying three fatty acids onto a glycerol-3-phosphate backbone. Phosphatidic acid is a key branch point; it can be dephosphorylated and acylated to form a triacylglycerol or combined with polar heads (choline, ethanolamine, serine) to form glycerophospholipids. Sphingolipids start with the condensation of palmitate and serine to form sphingosine. The addition of a fatty acid via an amide bond creates ceramide, which then combines with phosphocholine to form sphingomyelin. Isoprenoids are another lipid class derived from 5-carbon isoprene units (isopentenyl pyrophosphate). These include squalene ($30 C$), vitamins, and the ubiquitous dolichol used for protein glycosylation.

Cholesterol Biosynthesis and Metabolic Regulation

Cholesterol is a 27-carbon steroid essential for membrane integrity and as a precursor for bile salts and steroid hormones. Synthesis occurs in the endoplasmic reticulum and involves 5 stages. The rate-limiting step is the reduction of $HMG‐CoA$ to mevalonate by $HMG‐CoA$ reductase, which is inhibited by statins and glucagon, while being activated by insulin and low intracellular cholesterol levels. Mevalonate is converted into isoprene units, which condense into squalene and finally cyclize into lanosterol, which matures into cholesterol. Beyond energy signals, the cholesterol synthesis rate is also regulated by the recycling of Low-Density Lipoprotein ($LDL$) receptors; high internal cholesterol represses receptor synthesis, leading to higher blood levels.

Bile Acid Metabolism and Steroid Hormones

Bile acids are amphipathic derivatives of cholesterol produced in the liver and stored in the gallbladder. When conjugated with glycine or taurine, they become bile salts, which are efficient emulsifiers for dietary fat. Most bile salts ($95$%) are recycled from the intestine and returned to the liver via the enterohepatic circulation. Interruption of this recycling can lower blood cholesterol as the liver must draw from internal pools to produce more bile. Steroid hormones like progesterone, cortisol, and testosterone are also synthesized from cholesterol via selective hydroxylations and side-chain cleavage. Cortisol is the primary stress hormone that mobilizes energy stores by inducing gluconeogenic enzymes.

Nitrogen Metabolism: Proteolysis and Amino Acid Turnover

Proteins have limited lifespans and undergo continuous turnover (2-8 days on average). Dietary proteins are denatured by stomach acid and hydrolyzed into amino acids by pancreatic proteases (pepsin, trypsin, chymotrypsin). The resulting amino acid pool is used for protein synthesis, energy production, or hormone synthesis. Unlike glucose or fats, nitrogen cannot be stored; excess amino acids must be degraded. This involves removing the toxic alpha-amino group to produce an alpha-keto acid (carbon skeleton). Amino acids are either glucogenic (forming glucose precursors) or ketogenic (forming Acetyl-CoA). Leucine and Lysine are strictly ketogenic, while others like alanine are glucogenic. Glutamate and glutamine serve as the primary nitrogen shuttles, carrying waste ammonia from peripheral tissues like muscle to the liver.

The Urea Cycle and Ammonia Detoxification

Ammonia is highly toxic, specifically by depleting alpha-ketoglutarate and thus disabling the Krebs Cycle. Land animals detoxify ammonia by converting it into urea, a highly soluble, neutral, and stable diamide. The Urea Cycle occurs across the mitochondrial matrix and cytoplasm of hepatocytes. (1) Ammonia combines with bicarbonate to form carbamoyl phosphate (using 2 $ATP$). (2) Carbamoyl phosphate reacts with ornithine to form citrulline. (3) Citrulline condenses with aspartate to form argininosuccinate (the cycle's irreversible committed step, consuming 1 $ATP/2$ equivalents). (4) Argininosuccinate is split into arginine and fumarate. (5) Arginase hydrolyzes arginine to release urea and reset ornithine. The byproduct fumarate links to the Krebs Cycle (The Krebs-Urea Bicycle). Overall, eliminating one urea molecule costs roughly 4 $ATP$ equivalents.

Biosynthesis and Degradation of Nucleotides

Nucleotides serve as genetic templates (DNA/RNA), energy carriers ($ATP/GTP$), and metabolic regulators ($cAMP$). Purines (Adenine, Guanine) are synthesized de novo on a ribose-5-phosphate scaffold derived from $PRPP$, requiring inputs from glutamine, glycine, and aspartate. Their degradation leads to uric acid, a natural antioxidant that can cause gout or kidney stones if excessive ($hypouricemia$). Pyrimidines (Uracil, Cytosine, Thymine) are built as a free ring (orotate) before being attached to ribose. Deoxyribonucleotides for DNA are produced by ribonucleotide reductase, an enzyme that requires $NADPH$ for regeneration. Salvage pathways are vital for recycling free bases to save energy, particularly for purines using enzymes like $HGPRT$. High levels of $AMP$ during muscle fatigue activate $AMP‐activated$ protein kinase ($AMPK$), a master energy switch that inhibits anabolism (lipid/fat synthesis) and promotes catabolic energy production.

DNA Replication and Chromatin Structure

DNA is wrapped around clusters of positively charged histone proteins ($H2A$, $H2B$, $H3$, $H4$) to form nucleosomes. The further addition of $H1$ leads to higher-level compaction. Epigenetic modifications on histone tails manage gene accessibility: acetylation and phosphorylation relax chromatin to promote duplication/transcription, while methylation generally reinforces a dense, inactive state. Replication is semiconservative and occurs in directions $5'→3'$. While the leading strand is continuous, the lagging strand is synthesized as discrete Okazaki fragments subsequently joined by DNA ligase. DNA Polymerase III is exceptionally fast ($1000 bases/sec$) and possesses proofreading capabilities ($3'→5'$ exonuclease activity) to correct mismatches, ensuring high genetic fidelity that is not found in protein translation.

Metabolic Integration and Hormonal Coordination

Metabolism is integrated across tissues by the nervous system and hormones. The liver is the metabolic hub, processing nutrients to maintain blood glucose for the brain, which strictly requires glucose or ketone bodies and lacks energy stores. Muscles utilize phosphocreatine, glycogen, and fatty acids; during activity, they export lactate and alanine to the liver for glucose recycling. The heart is purely aerobic, preferring fatty acids ($60‐80$%). Adipose tissue acts as the primary energy depot. Insulin is the post-prandial anabolic signal (promoting glycogenesis and lipogenesis), while glucagon and adrenaline are catabolic signals (promoting glycogenolysis and lipolysis). AMPK acts as the intracellular energy sensor, ensuring that when cellular $ATP$ falls, pathways like glucose uptake and beta-oxidation are stimulated even in the absence of insulin.